A detailed history of Prosight Management, LP transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Prosight Management, LP holds 49,021 shares of TXG stock, worth $785,806. This represents 0.3% of its overall portfolio holdings.

Number of Shares
49,021
Previous 30,000 63.4%
Holding current value
$785,806
Previous $1.13 Million 15.29%
% of portfolio
0.3%
Previous 0.32%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$19.45 - $37.37 $369,958 - $710,814
19,021 Added 63.4%
49,021 $953,000
Q1 2024

May 15, 2024

BUY
$36.08 - $54.3 $1.08 Million - $1.63 Million
30,000 New
30,000 $1.13 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.52B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Prosight Management, LP Portfolio

Follow Prosight Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Prosight Management, LP with notifications on news.